153 related articles for article (PubMed ID: 2745269)
1. Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitin.
Brogan O; Garnett PA; Brown R
J Antimicrob Chemother; 1989 Apr; 23(4):660-2. PubMed ID: 2745269
[No Abstract] [Full Text] [Related]
2. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
3. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of chloramphenicol, clindamycin, metronidazole and cefoxitin against Bacteroides fragilis.
Soriano F; Ponte M; García-Hierro P
J Antimicrob Chemother; 1980 Sep; 6(5):679-80. PubMed ID: 7410288
[No Abstract] [Full Text] [Related]
5. Antibiotics of choice against Bacteroides fragilis.
Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
[No Abstract] [Full Text] [Related]
6. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
[TBL] [Abstract][Full Text] [Related]
7. [A diffusion method to find the antimicrobial sensitivity of Bacteroides fragilis. Comparative study with a plate dilution technic].
de la Torre Misiego F; López Bartolome O; Betriu Cabecerán C; Rodríguez Avial C; Cogollos Agruña R
Rev Clin Esp; 1984 Aug 15-31; 174(3-4):103-5. PubMed ID: 6515069
[No Abstract] [Full Text] [Related]
8. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
De Almeida AE; De Uzeda M
Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
[TBL] [Abstract][Full Text] [Related]
9. Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.
Wexler HM; Harris B; Carter WT; Finegold SM
Diagn Microbiol Infect Dis; 1986 Mar; 4(3):247-53. PubMed ID: 3956142
[TBL] [Abstract][Full Text] [Related]
10. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
13. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
García-Rodríguez JE; García-Sánchez JE
Rev Infect Dis; 1990; 12 Suppl 2():S142-51. PubMed ID: 2305180
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
Aldridge KE; Sanders CV
J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894
[TBL] [Abstract][Full Text] [Related]
15. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
Aldridge KE; Johnson WD
J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180
[TBL] [Abstract][Full Text] [Related]
16. Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.
Dubreuil L; Derriennic M; Sedallian A; Romond C; Courtieu AL
Infection; 1989; 17(3):197-200. PubMed ID: 2661442
[TBL] [Abstract][Full Text] [Related]
17. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
Wasilauskas BL
Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
Aldridge KE; Stratton CW
J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
